345830 Galectin-3, Human, Recombinant, E. coli

345830
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      345830-100UG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 100 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewRecombinant, human galectin-3 expressed in E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
          Catalogue Number345830
          Brand Family Calbiochem®
          SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
          References
          ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.
          Product Information
          FormLyophilized
          FormulationLyophilized from diH₂O.
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Physicochemical Information
          ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage -20°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          Certificates of Analysis

          TitleLot Number
          345830

          References

          Reference overview
          Legendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision30-June-2008 RFH
          SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
          DescriptionRecombinant, human galectin-3 expressed in and purified from E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
          FormLyophilized
          FormulationLyophilized from diH₂O.
          Purity≥95% by SDS-PAGE
          ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
          SolubilityReconstitute in sterile PBS. For use in carbohydrate binding studies, lactose should be removed by dialysis.
          Storage -20°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
          Toxicity Standard Handling
          ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.